Guidelines

Guidelines BHS

• Guidelines of the Belgian Hematological Society for newly diagnosed and relapsed follicular lymphoma anno 2019
• BHS guidelines for the treatment of newly diagnosed diffuse large B-cell lymphoma (DLBCL) anno 2020
• Diagnostic testing in myeloid malignancies by next-generation sequencing: recommendations from the Commission Personalised Medicine
• BHS guidelines for the treatment of marginal zone lymphomas: 2018 update
• BHS clinical guidelines on the management of acute complications in sickle cell disease
• Guidelines of the Belgian Hematology Society on the use of stem cell transplantation in lymphoproliferative diseases
• Hodgkin’s lymphoma: Belgian Hematology Society guidelines in diagnosis, treatment and follow-up
• Updated BHS guidelines for the treatment of chronic lymphocytic leukaemia, mantle cell lymphoma and Waldenström macroglobulinemia anno 2018
• BHS guidelines for the treatment of large granular lymphocyte and chronic prolymphocytic leukaemias
• BHS guidelines for primary central nervous system lymphoma
• Updated BHS guidelines for the treatment of chronic lymphocytic leukaemia anno 2016
• Diagnosis and treatment of AL Amyloidosis in 2015: Consensus guidelines of the Belgian Hematological Society
• Treatment of mantle cell lymphomas: Updated recommendations of the Belgian Hematological Society 2015
• Waldenström’s macroglobulinaemia: Belgian Hematology Society guidelines
• BHS 2013 recommendations for treatment of myelodysplastic syndromes
• BHS Guidelines for the treatment of Burkitt’s lymphoma
• The 2013 Belgian Hematological Society recommendations for the diagnosis and classification of myelodysplastic syndromes
• Update on the initial therapy of multiple myeloma
• Treatment of mantle cell lymphomas: recommendations of the Belgian Hematological Society
• Vaccination guidelines in haematopoietic transplant patients: recommendations from the BHS Transplant Committee
• BHS guidelines for the treatment of marginal zone lymphomas
• Disease characteristics in Belgian myelofibrosis patients and management guidelines anno 2013
• Guidelines for newly diagnosed diffuse large B-cell lymphoma (DLBCL) and relapsed DLBCL
• Primary immune thrombocytopenia in adults
• BHS guidelines for the treatment of chronic lymphocytic leukaemia anno 2012
• Point of view about new guidelines on ESAs (erythropoiesis-stimulating agents)
• Guidelines of the Belgian Hematological Society for newly diagnosed and relapsed follicular lymphoma 2012
• Use of alemtuzumab in B-cell chronic lymphocytic leukaemia: Belgian recommendations
• Guidelines of the Belgian Hemovigilance Report